6 completed, 1 terminated. 6 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow azimilide: new trials by email Literature Review of azimilide trials Research Report on azimilide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2) Azimilide Dihydrochloride, Placebo - Arrhythmias, Cardiac, Heart Diseases | Phase 3 | Terminated | Forest Laboratories | 240 | 2011-11-01 | 2013-05-06 |
| Effect of Azimilide Dihydrochloride on Renal Function Azimilide dihydrochloride, Placebo - Healthy | Phase 1 | Completed | Forest Laboratories | 21 | 2006-04-01 | 2017-02-01 |
| Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs) azimilide dihydrochloride - Arrhythmias | Phase 3 | Completed | Forest Laboratories | 330 | 2002-10-01 | 2017-02-01 |
| Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators Azimilide Dihydrochloride, placebo - Arrhythmia | Phase 3 | Completed | Forest Laboratories | 633 | 2001-09-01 | 2011-10-03 |
| Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation. Azimilide Dihydrochloride, Placebo, Sotalol - Atrial Fibrillation | Phase 3 | Completed | Forest Laboratories | 658 | 2001-02-01 | 2011-10-03 |
| Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation. Azimilide Dihydrochloride, Placebo - Atrial Fibrillation | Phase 3 | Completed | Forest Laboratories | 431 | 2000-12-01 | 2011-10-03 |
| Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation Azimilide Dihydrochloride, Placebo - Atrial Fibrillation | Phase 3 | Completed | Forest Laboratories | 446 | 2000-09-01 | 2011-10-03 |
Arrhythmias, Cardiac (3) · Atrial Fibrillation (3) · Cardiovascular Diseases (1) · Heart Diseases (1)
United States (6) · Canada (5) · Belgium (4) · France (4) · Germany (4) · Poland (4) · Spain (4) · Italy (3) · Netherlands (3) · Czechia (1) · Denmark (1) · Hungary (1) · Israel (1) · Russia (1) · Sweden (1)
Jose M Brum, MD (3) · David B Bharucha, MD, PhD (1) · Martin Phillips, MD (1) · Paloma Cuenca, MD (1) · Preston M Dunnmon, MD (1)